Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Plasma and Urine Pharmacokinetics of Parent Compound and a Metabolite of OC000459 in Healthy Male and Female Subjects

NCT02341521 is registered in ClinicalTrials.gov with Atopix Therapeutics, Ltd. as lead sponsor.

NCT NCT02341521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Plasma and Urine Pharmacokinetics of Parent Compound and a Metabolite of OC000459 in Healthy Male and Female Subjects
Lead sponsor
Atopix Therapeutics, Ltd.
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2015
Completion date
May 31, 2015
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma